Sana Biotechnology, Inc. (SANA)
Data as of , from SEC Form 4 filings.
See up to 3 months of SANA. The 7-day demo opens the 1M and 3M ranges and puts SANA on your watchlist.
Start 7-day demoLatest SANA insider trades
About Sana Biotechnology, Inc. (SANA)
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.
- SEATTLE, WA
- 142
- 2021
- XNAS
SANA Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 1 | 8,680 | |
| Option exercise | 2 | 250,000 | |
| Tax withholding / forfeiture | 1 | 41,158 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
SANA insider transactions (Form 4)
5125 Form 4 filings on record, the earliest from Oct 9, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Hans Edgar Bishop - Director | Grant or award | Common Stock | 8,680 footnote F1 | $0.00 | - | |
| ||||||
| Dhavalkumar Dhirajlal Patel - Officer | Option exercise | Common Stock | 125,000 | $0.00 | - | |
| Dhavalkumar Dhirajlal Patel - Officer | Tax withholding / forfeiture | Common Stock | 41,158 | $4.11 | $169K | |
| Dhavalkumar Dhirajlal Patel - Officer | Option exercise | Restricted Stock Units | 125,000 | $0.00 | - | |
| Hans Edgar Bishop | Grant or award | Common Stock | 6,297 footnote F1 | $0.00 | - | |
| ||||||
| Patrick Y. Yang | Grant or award | Stock Option (Right to Buy) | 90,000 | $0.00 | - | |
| Robert L. Rosiello | Grant or award | Stock Option (Right to Buy) | 90,000 | $0.00 | - | |
 Michelle Seitz | Grant or award | Stock Option (Right to Buy) | 90,000 | $0.00 | - | |
| Alise Reicin | Grant or award | Stock Option (Right to Buy) | 90,000 | $0.00 | - | |
| Richard Mulligan | Grant or award | Stock Option (Right to Buy) | 90,000 | $0.00 | - | |
| Hans Edgar Bishop | Grant or award | Stock Option (Right to Buy) | 90,000 | $0.00 | - | |
 Joshua H. Bilenker | Grant or award | Stock Option (Right to Buy) | 90,000 | $0.00 | - | |
 Robert Nelsen - Director | Grant or award | Stock Option (Right to Buy) | 90,000 | $0.00 | - | |
| Hans Edgar Bishop | Grant or award | Common Stock | 7,763 footnote F1 | $0.00 | - | |
| ||||||
 Steve Harr - Officer | Option exercise | Common Stock | 41,666 | $0.00 | - | |
| Steve Harr - Officer | Option exercise | Common Stock | 50,000 | $0.00 | - | |
| Steve Harr - Officer | Tax withholding / forfeiture | Common Stock | 11,526 | $3.13 | $36K | |
| Steve Harr - Officer | Tax withholding / forfeiture | Common Stock | 12,819 | $3.10 | $40K | |
| Steve Harr - Officer | Option exercise | Restricted Stock Units | 41,666 | $0.00 | - | |
| Steve Harr - Officer | Option exercise | Restricted Stock Units | 50,000 | $0.00 | - | |
| Susan D. Wyrick - Officer | Option exercise | Common Stock | 10,416 | $0.00 | - | |
| Susan D. Wyrick - Officer | Option exercise | Common Stock | 3,250 | $0.00 | - | |
| Susan D. Wyrick - Officer | Tax withholding / forfeiture | Common Stock | 3,342 | $3.13 | $10K | |
| Susan D. Wyrick - Officer | Tax withholding / forfeiture | Common Stock | 1,045 | $3.10 | $3K | |
| Susan D. Wyrick - Officer | Option exercise | Restricted Stock Units | 10,416 | $0.00 | - | |
| Susan D. Wyrick - Officer | Option exercise | Restricted Stock Units | 3,250 | $0.00 | - | |
| Susan D. Wyrick - Officer | Grant or award | Restricted Stock Units | 45,833 | $0.00 | - | |
| Susan D. Wyrick - Officer | Grant or award | Stock Option (Right to Buy) | 206,250 | $0.00 | - | |
| Steve Harr - Officer | Grant or award | Restricted Stock Units | 200,000 | $0.00 | - | |
| Steve Harr - Officer | Grant or award | Stock Option (Right to Buy) | 900,000 | $0.00 | - | |
| Susan D. Wyrick - Officer | Option exercise | Common Stock | 1,525 | $0.00 | - | |
| Susan D. Wyrick - Officer | Tax withholding / forfeiture | Common Stock | 491 | $3.91 | $2K | |
| Susan D. Wyrick - Officer | Option exercise | Restricted Stock Units | 1,525 | $0.00 | - | |
| Brian Piper - Officer | Grant or award | Restricted Stock Units | 200,000 | $0.00 | - | |
| Brian Piper - Officer | Grant or award | Stock Option (Right to Buy) | 900,000 | $0.00 | - | |
| Susan D. Wyrick - Officer | Option exercise | Common Stock | 3,400 | $0.00 | - | |
| Susan D. Wyrick - Officer | Tax withholding / forfeiture | Common Stock | 873 | $5.22 | $5K | |
| Susan D. Wyrick - Officer | Option exercise | Restricted Stock Units | 3,400 | - footnote F1 | - | |
| ||||||
| Susan D. Wyrick - Officer | Tax withholding / forfeiture | Common Stock | 2,565 | $4.44 | $11K | |
| Susan D. Wyrick - Officer | Option exercise | Common Stock | 10,000 | $0.00 | - | |
| Susan D. Wyrick - Officer | Tax withholding / forfeiture | Common Stock | 2,567 | $2.32 | $6K | |
| Susan D. Wyrick - Officer | Option exercise | Common Stock | 10,000 | $0.00 | - | |
| Susan D. Wyrick - Officer | Grant or award | Restricted Stock Units | 3,400 | $0.00 | - | |
| Susan D. Wyrick - Officer | Grant or award | Stock Option (Right to Buy) | 5,100 | $0.00 | - | |
| Susan D. Wyrick - Officer | Option exercise | Restricted Stock Units | 10,000 | $0.00 | - | |
| Susan D. Wyrick - Officer | Option exercise | Restricted Stock Units | 10,000 | $0.00 | - | |
| Hans Edgar Bishop | Grant or award | Common Stock | 5,628 footnote F1 | $0.00 | - | |
| ||||||
| Hans Edgar Bishop | Grant or award | Common Stock | 7,842 | $0.00 | - | |
| Robert Nelsen | Grant or award | Stock Option (Right to Buy) | 80,000 | $0.00 | - | |
 Mary Agnes Wilderotter | Grant or award | Stock Option (Right to Buy) | 80,000 | $0.00 | - | |
| Hans Edgar Bishop | Grant or award | Common Stock | 5,938 | $0.00 | - | |
SANA insider trading FAQ
What is the latest insider trade for SANA?
Sana Biotechnology, Inc. (SANA) had 2 insider filings in the last 90 days, with the most recent on 2026-10-06. The full record for SANA runs to 25 Form 4 filings, the earliest from 2024-10-09. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying SANA stock?
No insider purchases of SANA were filed in the last 90 days.
How many insiders are selling SANA stock?
No insider sales of SANA were filed in the last 90 days.
Where can I see SANA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects SANA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Hans Edgar Bishop view on EDGAR
- - Dhavalkumar Dhirajlal Patel view on EDGAR
- - Hans Edgar Bishop view on EDGAR
- - Patrick Y. Yang view on EDGAR
- - Robert L. Rosiello view on EDGAR
- - Michelle Seitz view on EDGAR
- - Alise Reicin view on EDGAR
- - Richard Mulligan view on EDGAR
- - Hans Edgar Bishop view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where SANA's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow SANA with a 7-day demo
- SANA on your watchlist
- Every SANA Form 4 filing on record
- Up to 3 months of SANA price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
